Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 158

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Hypertension and abnormal fat distribution but not insulin resistance in mice with P465L PPARγ

Open access
Tsai, Yau-Sheng, Kim, Hyo-Jeong, Takahashi, Nobuyuki, Kim, Hyung-Suk, Hagaman, John R., Kim, Jason K., Maeda, Nobuyo·2004·Journal of Clinical Investigation

Abstract

Peroxisome proliferator-activated receptor γ (PPARγ), the molecular target of a class of insulin sensitizers, regulates adipocyte differentiation and lipid metabolism.A dominant negative P467L mutation in the ligand-binding domain of PPARγ in humans is associated with severe insulin resistance and hypertension.Homozygous mice with the equivalent P465L mutation die in utero.Heterozygous mice grow normally and have normal total adipose tissue weight.However, they have reduced interscapular brown adipose tissue and intra-abdominal fat mass, and increased extra-abdominal subcutaneous fat, compared with wild-type mice.They have normal plasma glucose levels and insulin sensitivity, and increased glucose tolerance.However, during high-fat feeding, their plasma insulin levels are mildly elevated in association with a significant increase in pancreatic islet mass.They are hypertensive, and expression of the angiotensinogen gene is increased in their subcutaneous adipose tissues.The effects of P465L on blood pressure, fat distribution, and insulin sensitivity are the same in both male and female mice regardless of diet and age.Thus the P465L mutation alone is sufficient to cause abnormal fat distribution and hypertension but not insulin resistance in mice.These results provide genetic evidence for a critical role for PPARγ in blood pressure regulation that is not dependent on altered insulin sensitivity.Nonstandard abbreviations used: adipocyte fatty acid-binding protein (aP2); angiotensin I (AngI); angiotensin II (ATII); angiotensin II type I receptor (AT1R); angiotensin II type II receptor (AT2R); angiotensinogen (AGT); brown adipose tissue (BAT); glucose transporter 4 (Glut4); hepatic glucose production (HGP); heterozygous for PPARγ deficiency (Pparg +/-); intraperitoneal glucose tolerance test (IPGTT); intraperitoneal insulin tolerance test (IPITT); lipoprotein lipase (LPL); peroxisome proliferator-activated receptor γ (PPARγ); phosphoenolpyruvate carboxykinase (PEPCK); renin-angiotensin system (RAS); retinoid X receptor (RXR); thiazolidinedione (TZD); uncoupling protein 1 (UCP1). Conflict of interest:The authors have declared that no conflict of interest exists.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci200420964

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 158

Metadata

Authors
Tsai, Y.-S., Kim, H.-J., Takahashi, N., Kim, H.-S., Hagaman, J. R., Kim, J. K., & Maeda, N.
Venue
Journal of Clinical Investigation
Published
2004-07-15
Volume
114
Issue
2
Pages
240-249
ISSN
0021-9738 (ISSN-L)
OpenAlex
W2023624937
Cited by
158
References
3
FWCI
5.25
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Hypertension and abnormal fat distribution but not insulin resistance in mice with P465L PPARγ. https://app.cochat.ai/papers/10.1172/jci200420964
The paper
Tsai, Y.-S., Kim, H.-J., Takahashi, N., Kim, H.-S., Hagaman, J. R., Kim, J. K., & Maeda, N. (2004). Hypertension and abnormal fat distribution but not insulin resistance in mice with P465L PPARγ. Journal of Clinical Investigation. https://doi.org/10.1172/jci200420964

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.